Court Rules for NaPro In Patent Dispute over Cancer Drug
The Federal District Court in the Western District of Pennsylvania ruled in favor of NaPro BioTherapeutics in its patent infringement suit against generic rival Mylan Laboratories, according to a statement issued...To view the full article, register now.
Already a subscriber? Click here to view full article